Edinburgh Research Explorer

The long-acting COX-2 inhibitor mavacoxib (Trocoxil (TM)) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro

Research output: Contribution to journalArticle

Standard

The long-acting COX-2 inhibitor mavacoxib (Trocoxil (TM)) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. / Pang, Lisa Y.; Argyle, Sally A.; Kamida, Ayako; Morrison, Katherine O'Neill; Argyle, David J.

In: BMC Veterinary Research, Vol. 10, No. 1, 184, 05.09.2014, p. 184.

Research output: Contribution to journalArticle

Harvard

Pang, LY, Argyle, SA, Kamida, A, Morrison, KON & Argyle, DJ 2014, 'The long-acting COX-2 inhibitor mavacoxib (Trocoxil (TM)) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro', BMC Veterinary Research, vol. 10, no. 1, 184, pp. 184. https://doi.org/10.1186/s12917-014-0184-9

APA

Pang, L. Y., Argyle, S. A., Kamida, A., Morrison, K. ON., & Argyle, D. J. (2014). The long-acting COX-2 inhibitor mavacoxib (Trocoxil (TM)) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. BMC Veterinary Research, 10(1), 184. [184]. https://doi.org/10.1186/s12917-014-0184-9

Vancouver

Pang LY, Argyle SA, Kamida A, Morrison KON, Argyle DJ. The long-acting COX-2 inhibitor mavacoxib (Trocoxil (TM)) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. BMC Veterinary Research. 2014 Sep 5;10(1):184. 184. https://doi.org/10.1186/s12917-014-0184-9

Author

Pang, Lisa Y. ; Argyle, Sally A. ; Kamida, Ayako ; Morrison, Katherine O'Neill ; Argyle, David J. / The long-acting COX-2 inhibitor mavacoxib (Trocoxil (TM)) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. In: BMC Veterinary Research. 2014 ; Vol. 10, No. 1. pp. 184.